Previously, the Taiwan Food and Drug Administration (TFDA) has issued several notices to revise information related to traditional Chinese medicine pharmaceutical products and to ensure an increased quality of the products for the safety of public health, especially for products focused on treating the COVID-19.
Taiwan foresees high demands for Traditional Chinese medicine and medical products, particularly within ASEAN countries. In countries such as Thailand and Malaysia, there is a large population of Chinese people residing there that are familiar with traditional Chinese medicine and uses it to treat diseases. They create a good user base for expanding the knowledge on traditional Chinese medicines and its beneficial usage. More importantly, Thais and Malaysians have high purchasing power of health products and services.